Evidence-Based Decision-Making in Asia-Pacific with Rapidly Changing Health-Care Systems: Thailand, South Korea, and Taiwan. Thidaporn Jirawattanapisal1 Pritaporn Kingkaew2 Tae-Jin Lee3 Ming-Chin Yang4 1International Health Policy Program, Ministry of Public Health, Muang Nonthaburi,Thailand; 2

Multi-criteria decision analysis to prioritize health interventions: Capitalizing on first experiences. Rob Baltussen1, Sitapon Youngkong11,2, Francesco Paolucci3, Louis Niessen4 1 Department of Primary and Community Care, Radboud University Nijmegen Medical Center, The Netherlands 2 Health I

Criteria for priority setting of HIV/AIDS interventions in Thailand: a discrete choice experiment Sitaporn Youngkong*1,2, Rob Baltussen*1, Sripen Tantivess*2, Xander Koolman*3 and Yot Teerawattananon*2 1 Nijmegen International Center for Health Systems Research and Education (NICHE), Department of

The 10th HTAsiaLink Annual Conference is the first physical conference after the pandemic hit for HTAsiaLink network. Under the theme ‘The Role of HTA in the New Normal: Driving the post-COVID health systems through evidence-informed decisions,’ a broad range of discussions were sparked and would co

The EVIDEM framework and its usefulness for priority setting across a broad range of health interventions Download at http://www.resource-allocation.com/content/9/1/8 Sitaporn Youngkong1,2*, Noor Tromp1† and Dereck Chitama1,3† * Corresponding author: Sitaporn Youngkong [email protected]

Health Related Quality of Life among Patient with Tuberculosis and HIV in Thailand. Wanitchaya Kittikraisak , Pritaporn Kingkaew, Yot Teerawattananon, Jomkwan Yothasamut, Supalert Natesuwan, Weerawat Manosuthi, Virasakdi Chongsuvivatwong, Sara J. Whitehead Abstract Introduction Health util

Evidence to Inform Decision Makers in Thailand: A Cost-Effectiveness Analysis of Screening and Treatment Strategies for Postmenopausal Osteoporosis. Pritaporn Kingkaew, BPharm, MSccorrespondenceemail, Usawadee Maleewong, BPharm, PhD, Chardpraorn Ngarmukos, MD, Yot Teerawattananon, MD, PhD Abst

Involvement of consumers in health technology assessment activities by INAHTA agencies. David Haileya1, Sophie Werköa2, Rugayah Bakria3, Alun Camerona4, Britta Göhlena5, Susan Mylesa6, Jasmine Pwua7 and Jomkwan Yothasamuta8 For the INAHTA Working Group on Impact of HTA a1 University of Wollong

A cost–utility analysis of alternative drug regimens for newly diagnosed severe lupus nephritis patients in Thailand. Adun Mohara1, Román Pérez Velasco1, Naiyana Praditsitthikorn1,2, Yingyos Avihingsanon3 and Yot Teerawattananon1 1Health Intervention and Technology Assessment Program (HITAP),

Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand. Waranya Rattanavipapong1, Tanunya Koopitakkajorn1, Naiyana Praditsitthikorn1,2,*, Surakameth Mahasirimongkol3 andYot Teerawattananon1 Summary Purpose There is strong evidence o